Founders Bay Holdings (FDBH)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Founders Bay Holdings (FDBH) with AI Score 58/100 (Hold). Founders Bay Holdings (FDBH) provides medical diagnostic services, focusing on the operation and administration of MRI equipment in diagnostic centers. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 18, 2026Founders Bay Holdings (FDBH) Healthcare & Pipeline Overview
Founders Bay Holdings, operating in the healthcare information services sector, specializes in medical diagnostic services through MRI equipment. Catering to HMOs and PPOs, the company, established in 1986, faces competition from larger healthcare providers while maintaining a strong profit margin of 43.2%.
Investment Thesis
Founders Bay Holdings (FDBH) presents a focused investment opportunity within the medical diagnostic services sector. The company's high profit margin of 43.2% and gross margin of 74.8% indicate operational efficiency. However, the company's small size, with only 7 employees, and its presence on the OTC market introduce liquidity and regulatory risks. Growth catalysts include potential expansion of MRI service offerings and strategic partnerships with healthcare providers. The negative beta of -4.75 suggests the stock may move inversely to the market. Investors should carefully consider the OTC market risks and limited information availability before investing. The absence of a dividend yield may deter income-focused investors.
Based on FMP financials and quantitative analysis
Key Highlights
- Profit Margin of 43.2% indicates strong operational efficiency within the medical diagnostic services niche.
- Gross Margin of 74.8% suggests effective cost management in providing MRI diagnostic services.
- Beta of -4.75 indicates a potential inverse correlation with the broader market, offering diversification benefits.
- Specialization in MRI diagnostic services allows FDBH to cater to specific needs of healthcare providers.
- Established in 1986, FDBH has a long operating history in the healthcare sector, demonstrating resilience.
Competitors & Peers
Strengths
- High profit margin of 43.2%.
- Long operating history since 1986.
- Specialized expertise in MRI diagnostic services.
- Established relationships with healthcare providers.
Weaknesses
- Small size with only 7 employees.
- Limited geographic reach.
- Reliance on MRI technology.
- Trades on the OTC market.
Catalysts
- Upcoming: Potential partnerships with healthcare providers to expand service reach.
- Upcoming: Expansion of MRI service offerings to include advanced diagnostic procedures.
- Ongoing: Continued focus on maintaining high profit margins through efficient operations.
- Ongoing: Leveraging established relationships with local healthcare providers.
Risks
- Potential: Limited liquidity due to trading on the OTC market.
- Potential: Increased competition from larger healthcare providers.
- Potential: Regulatory changes affecting the healthcare industry.
- Ongoing: Reliance on MRI technology, which could become obsolete.
- Ongoing: Limited financial disclosure due to OTC Other listing.
Growth Opportunities
- Expansion of MRI Service Offerings: FDBH can expand its service offerings by investing in advanced MRI technologies and specialized diagnostic procedures. The global MRI market is projected to reach $7.8 billion by 2027, driven by increasing prevalence of chronic diseases and technological advancements. By offering specialized MRI services, FDBH can attract new clients and increase revenue within the next 2-3 years.
- Strategic Partnerships with Healthcare Providers: Forming strategic partnerships with HMOs, PPOs, and other healthcare providers can provide FDBH with a steady stream of patients and revenue. The healthcare industry is increasingly focused on value-based care, which emphasizes collaboration and integrated services. By partnering with healthcare providers, FDBH can enhance its market reach and improve patient outcomes, with potential benefits materializing within the next 1-2 years.
- Geographic Expansion: FDBH can expand its operations to new geographic markets by establishing new diagnostic centers or acquiring existing facilities. The demand for MRI services is growing in emerging markets, driven by increasing healthcare spending and awareness. Expanding to new markets can diversify FDBH's revenue streams and reduce its reliance on the Las Vegas area, with potential expansion starting in the next 3-5 years.
- Telemedicine Integration: Integrating telemedicine solutions into its service offerings can allow FDBH to reach a wider patient base and improve access to diagnostic services. Telemedicine is experiencing rapid growth, driven by increasing adoption of digital health technologies and favorable regulatory changes. By offering remote MRI consultations and image analysis, FDBH can enhance its competitive advantage and attract tech-savvy patients, with integration potentially starting within the next 1-2 years.
- Data Analytics and Reporting: Leveraging data analytics to improve diagnostic accuracy and reporting can enhance FDBH's value proposition to healthcare providers. The healthcare industry is increasingly focused on data-driven decision-making, and providers are seeking solutions that can help them improve patient outcomes and reduce costs. By offering advanced data analytics and reporting capabilities, FDBH can differentiate itself from competitors and attract data-conscious clients, with implementation potentially starting within the next 1-2 years.
Opportunities
- Expansion of MRI service offerings.
- Strategic partnerships with healthcare providers.
- Geographic expansion to new markets.
- Integration of telemedicine solutions.
Threats
- Competition from larger healthcare providers.
- Technological advancements in diagnostic imaging.
- Regulatory changes in the healthcare industry.
- Economic downturn affecting healthcare spending.
Competitive Advantages
- Established relationships with local healthcare providers.
- Specialized expertise in MRI diagnostic services.
- High profit margin indicating efficient operations.
- Long operating history since 1986.
About FDBH
Founded in 1986 and based in Las Vegas, Nevada, Founders Bay Holdings (FDBH) operates within the medical diagnostic services industry. The company focuses on developing, operating, and administering magnetic resonance imaging (MRI) equipment in medical diagnostic centers. These centers provide crucial medical diagnostic services to a variety of healthcare organizations, including health maintenance organizations (HMOs), preferred provider organizations (PPOs), trade unions, clinics, and other healthcare providers. FDBH's business model centers around providing access to MRI technology and diagnostic services, enabling healthcare providers to offer advanced imaging capabilities to their patients. The company's services are essential for accurate and timely diagnoses, contributing to improved patient outcomes. While the company is relatively small, with only 7 employees, its high profit margin of 43.2% suggests efficient operations and a strong market position within its niche. Founders Bay Holdings navigates a competitive landscape, focusing on specialized service offerings to maintain its relevance and profitability in the healthcare sector.
What They Do
- Develops and operates magnetic resonance imaging (MRI) equipment.
- Administers MRI equipment in medical diagnostic centers.
- Provides medical diagnostic services to health maintenance organizations (HMOs).
- Offers diagnostic services to preferred provider organizations (PPOs).
- Serves trade unions with medical diagnostic services.
- Provides diagnostic services to clinics and other healthcare providers.
Business Model
- Generates revenue by providing MRI diagnostic services.
- Partners with healthcare providers to offer diagnostic imaging.
- Operates medical diagnostic centers equipped with MRI technology.
Industry Context
Founders Bay Holdings operates in the healthcare information services industry, which is experiencing growth due to increasing demand for diagnostic imaging and data-driven healthcare solutions. The market is competitive, with larger players like AOLS and AVTI offering a broader range of services. FDBH's focus on MRI diagnostic services allows it to carve out a niche, but it must adapt to evolving technology and regulatory changes. The industry is also influenced by trends such as telemedicine and remote patient monitoring, which could impact the demand for traditional diagnostic centers.
Key Customers
- Health maintenance organizations (HMOs).
- Preferred provider organizations (PPOs).
- Trade unions.
- Clinics.
- Other healthcare providers.
Financials
Chart & Info
Founders Bay Holdings (FDBH) stock price: Price data unavailable
Latest News
No recent news available for FDBH.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FDBH.
Price Targets
Wall Street price target analysis for FDBH.
MoonshotScore
What does this score mean?
The MoonshotScore rates FDBH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Jacob Simone
Managing
Jacob Simone is the managing leader of Founders Bay Holdings, overseeing a team of 7 employees. Information regarding his prior experience and educational background is not available. As the leader, Simone is responsible for the strategic direction, operational management, and financial performance of the company, which specializes in medical diagnostic services.
Track Record: Due to limited information, Jacob Simone's specific achievements and strategic decisions at Founders Bay Holdings are unknown. Assessing his track record is challenging without further data on company performance and key milestones during his tenure. His leadership is pivotal in navigating the competitive healthcare landscape and ensuring the company's continued operation.
FDBH OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Founders Bay Holdings may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure due to the OTC Other listing.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Lack of regulatory oversight compared to major exchanges.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Determine the company's ownership structure and shareholder base.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Long operating history since 1986.
- Specialized expertise in MRI diagnostic services.
- High profit margin of 43.2%.
- Physical headquarters in Las Vegas, Nevada.
Common Questions About FDBH
What does Founders Bay Holdings do?
Founders Bay Holdings specializes in providing medical diagnostic services, primarily through the operation and administration of magnetic resonance imaging (MRI) equipment in medical diagnostic centers. The company caters to a variety of healthcare providers, including health maintenance organizations (HMOs), preferred provider organizations (PPOs), trade unions, clinics, and other healthcare entities. Their business model revolves around offering MRI diagnostic services, contributing to accurate and timely diagnoses for patients within these healthcare networks.
What do analysts say about FDBH stock?
Due to the company's OTC listing and limited analyst coverage, there is no readily available analyst consensus on Founders Bay Holdings. Key valuation metrics include a P/E ratio of 0.00, reflecting the company's earnings, and a profit margin of 43.2%, indicating strong profitability. Growth considerations should focus on the company's ability to expand its service offerings, form strategic partnerships, and navigate the competitive healthcare landscape. However, the lack of analyst coverage and limited information availability necessitate caution and thorough due diligence.
What are the main risks for FDBH?
Founders Bay Holdings faces several risks, including limited liquidity due to its trading on the OTC market, which can make it difficult to buy or sell shares. The company also faces competition from larger healthcare providers with greater resources and broader service offerings. Regulatory changes in the healthcare industry could impact the company's operations and profitability. Additionally, the company's reliance on MRI technology exposes it to the risk of technological obsolescence. The limited financial disclosure associated with its OTC Other listing also increases investment risk.
What are the key factors to evaluate for FDBH?
Founders Bay Holdings (FDBH) currently holds an AI score of 58/100, indicating moderate score. Key strength: High profit margin of 43.2%.. Primary risk to monitor: Potential: Limited liquidity due to trading on the OTC market.. This is not financial advice.
How frequently does FDBH data refresh on this page?
FDBH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven FDBH's recent stock price performance?
Recent price movement in Founders Bay Holdings (FDBH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: High profit margin of 43.2%.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider FDBH overvalued or undervalued right now?
Determining whether Founders Bay Holdings (FDBH) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying FDBH?
Before investing in Founders Bay Holdings (FDBH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is limited due to the company's OTC listing and lack of analyst coverage.
- Financial data is based on available information and may not be comprehensive.
- OTC market investments carry higher risks than exchange-listed securities.